SEC Form 4/A · accession 0001415889-16-007497
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Alan Wayne Schoenbart
Officer — INTERIM CEO, CFO AND SECRETARY
Period of report
Mar 1, 2016
Accepted (ET)
Nov 23, 2016 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2016 | A | 100,000 | $0.00 | A | 102,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person is amending the Form 4 originally filed to report a change in vesting schedule so that restricted shares vest upon the earlier to occur of (i) September 1, 2017, or (ii) the day immediately following the date on which the Company announces receipt of proceeds of at least $250,000 from any source of financing.